Near-Infrared Light Activated Chemotherapeutic Prodrug

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Schanze Kirk

Funded by

San Antonio Medical Foundation

Research Start Date

10/01/2023

Status

Active

Applied Research

Collaborative Project

Basic Research

Cancer

Bioscience Research Panel